Inhibition of contact sensitivity reactions to DNFB by topical cyclosporin application in the guinea-pig.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Clinical and Experimental Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 3971598PMCID PMC1577184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kinetics of the effect of a single dose of cyclosporin-A on antibody and cell mediated immune responses in the guinea pig.

  1984cited by this paper
• Absence of dependence on cyclophosphamide-sensitive suppressor cells in suppression of cell-mediated immunity by cyclosporine in the guinea pig.

  1984cited by this paper
• Modification of delayed-type hypersensitivity reactions to ovalbumin in cyclosporin A-treated guinea-pigs.

  1983cited by this paper
• Immunobiology of cyclosporin A--a review.

  1983cited by this paper
• Effect of Cyclophosphamide on Immunological Control Mechanisms

  1982cited by this paper
• Nephrotoxicity of cyclosporin A in liver and kidney transplant patients.

  1981cited by this paper
• Cyclosporin A applied topically to the recipient eye inhibits corneal graft rejection.

  1981cited by this paper
• A radioimmunoassay to measure cyclosporin A in plasma and serum samples.

  1981cited by this paper
• Pathological changes developing in the rat during a 3-week course of high dosage cyclosporin A and their reversal following drug withdrawal.

  1981cited by this paper
• Cyclosporin A in patients receiving renal allografts from cadaver donors.

  1978cited by this paper
• Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

  1977cited by this paper

• Analysis of the cumulative changes in Graves' disease thyroid glands points to IFN signature, plasmacytoid DCs and alternatively activated macrophages as chronicity determining factors.

  2011cites this paper
• Discovery of Topical Calcineurin Inhibitors and Pharmacological Profile of Pimecrolimus

  2006cites this paper
• Lack of demonstrable effect of cyclosporin A on human epidermal Langerhans cell function

  2004cites this paper
• Intratympanic immunosuppressives for prevention of immune-mediated sensorineural hearing loss.

  2000cites this paper
• Culture of human epidermal Langerhans cells in a skin equivalent

  1998cites this paper
• Site-Specific Immunosuppression with Topical Agents

  1996cites this paper
• Overview of a 10-year experience on methods and compositions for inducing site-specific immunosuppression with topical immunosuppressants.

  1996cites this paper
• In vivo pharmacological effects of ciclosporin and some analogues.

  1996cites this paper
• Digital image analysis of major histocompatibility complex class I and class II expression during site-specific immune suppression with topical cyclosporine.

  1995cites this paper
• Percutaneous absorption and dermal delivery of cyclosporin A.

  1995cites this paper
• Effect of Topical Preparation of Mycophenolic Acid on Experimental Allergic Contact Dermatitis of Guinea‐pigs Induced by Dinitrofluorobenzene

  1994cites this paper
• Cyclosporin A in the treatment of chronic dermatitis of the hands

  1994cites this paper
• Suppressive effect of topical cyclosporin A on rechallenge system of murine contact hypersensitivity

  1993cites this paper
• Effects of cyelosporin A on resident and passenger immune cells of normal human skin and UV‐induced erythema reactions

  1992cites this paper
• Pharmacokinetic model for subcutaneous absorption of cyclosporine in the rabbit during chronic treatment.

  1992cites this paper
• Topical cyclosporin A treatment in psoriasis and other dermatological diseases: Theoretical and practical aspects.

  1992cites this paper
• ALOPECIA UNIVERSALIS TREATED WITH ORAL CYCLOSPORINE A AND PREDNISOLONE: IMMUNOLOGIC STUDIES

  1992cites this paper
• Effect of a new topical cyclosporin formulation on human allergic contact dermatitis

  1992cites this paper
• Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases?

  1992cites this paper
• Squalene peroxides may contribute to ultraviolet light-induced immunological effects.

  1991cites this paper
• Lack of efficacy of topical cyclosporin A in atopic dermatitis and allergic contact dermatitis.

  1991cites this paper
• Inhibitory effect of cyclosporin A on antigen and alloantigen presenting capacity of human epidermal Langerhans cells

  1991cites this paper
• Suppressive Effect of Orally Administered Cyclosporin A on Rechallenge System of Murine Contact Hypersensitivity

  1991cites this paper
• Topical cyclosporine in male pattern alopecia.

  1990cites this paper
• Enhanced percutaneous absorption of a novel topical cyclosporin A formulation and assessment of its immunosuppressive activity

  1990cites this paper
• The effect of cyclosporin on human epidermal keratinocytes in vitro

  1990cites this paper
• Intralesional cyclosporine in the treatment of psoriasis. A clinical, immunologic, and pharmacokinetic study.

  1990cites this paper
• Cyclosporin A levels in suction‐blister fluid of patients with psoriasis treated systemically

  1990cites this paper
• Immunosuppressive effects of clonidine on the induction of contact sensitization in the balb/c mouse.

  1990cites this paper
• Site-specific suppression of cell-mediated immunity by cyclosporine.

  1990cites this paper
• Topical cyclosporine: effects on allergic contact dermatitis in guinea pigs *

  1989cites this paper
• Immunohistochemical analysis of contact sensitivity reactions in the guinea-pig using novel monoclonal antibodies: the influence of topical cyclosporin A.

  1989cites this paper
• Cyclosporine in dermatology.

  1989cites this paper
• Topical cyclosporine A inhibits the phorbol ester induced hyperplastic inflammatory response but not protein kinase C activation in mouse epidermis.

  1989cites this paper
• Topical cyclosporine and contact dermatitis in guinea pig and man.

  1989cites this paper
• Double-blind randomized placebo-controlled trial of local cyclosporine in atopic dermatitis.

  1989cites this paper
• Pharmacology of cyclosporine (sandimmune). IV. Pharmacological properties in vivo.

  1989cites this paper
• The Prosser White oration 1988. Mischievous metals--chromate, cobalt, nickel and mercury.

  1989cites this paper
• Cyclosporin A and skin disease

  1989cites this paper
• Mischievous metals–chromate, cobalt, nickel and mercury

  1989cites this paper
• A preliminary open study of topical cyclosporin for hypertrophic lichen planus

  1989cites this paper
• The influence of cyclosporin A on T cell activation, cytokine gene expression and cell-mediated immunity

  1989cites this paper
• Double-blind randomized placebo-controlled trial of local cyclosporine in atopic dermatitis.

  1989cites this paper
• The effect of cyclosporine on epidermal cells. I. Cyclosporine inhibits accessory cell functions of epidermal Langerhans cells in vitro.

  1988cites this paper
• Topical application of cyclosporine on guinea pig allergic contact dermatitis.

  1988cites this paper
• Percutaneous absorption of cyclosporin.

  1988cites this paper
• Comparison of the efficacy of unilateral, bilateral, and oral cyclosporine in experimental immunogenic uveitis in rabbits.

  1988cites this paper
• Transdermal application of cyclosporine prolongs skin allograft survival.

  1988cites this paper
• [Cyclosporin in dermatology].

  1988cites this paper
• Treatment of severe alopecia areata by topical applications of cyclosporine: comparative trial versus placebo in 43 patients.

  1988cites this paper
• The effect of topical cyclosporin A on the elicitation phase of allergic contact dermatitis

  1988cites this paper
• Effects of oral and topical cyclosporine in male pattern alopecia.

  1988cites this paper
• Percutaneous absorption of cyclosporin.

  1988cites this paper
• Cyclosporine A inhibits accessory cell and antigen-presenting cell functions of epidermal Langerhans cells.

  1988cites this paper
• Subcutaneous absorption of cyclosporine in rabbits.

  1988cites this paper
• Topical cyclosporin and immunologically-mediated skin disorders.

  1987cites this paper
• Immunobiology of cyclosporin A, with particular reference to its effects on delayed hypersensitivity and regulatory T-cell functions.

  1987cites this paper
• Effect of Cyclosporin A on Contact Sensitivity to DNCB in Guinea Pigs

  1987cites this paper
• Inhibition of contact sensitivity to oxazolone by the calmodulin inhibitor trifluoroperazine.

  1987cites this paper
• [Immunopharmacology of cyclosporin A].

  1986cites this paper
• Topical cyclosporin A in nickel contact hypersensitivity: results of a preliminary clinical and immunohistochemical investigation.

  1986cites this paper
• Effect of cyclosporin A on the T-effector and T-suppressor cell response in contact sensitivity.

  1986cites this paper
• Topical cyclosporin in alopecia areata and nickel contact dermatitis.

  1986cites this paper
• Cyclosporin A.

  1986cites this paper
• Placebo-controlled trial of topical cyclosporin in severe alopecia areata.

  1986cites this paper
• INDIVIDUALIZATION OF CYCLOSPORINE THERAPY USING PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS

  1985cites this paper